Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

Sarcoma

HUB

non-CME

Industry Spotlight Presented by SpringWorks: Presentation on OGSIVEO (nirogacestat), the first and only FDA-approved therapy for adult patients with progressing desmoid tumors who require systemic treatment.

Friday, March 22, 2024
11:15am – 11:35am ET
Location: SSO HUB Theater

    Industry Presenter(s)

  • Jeffrey D. Wayne, MD (he/him/his)

    Chief of Division of Surgical Oncology, Professor of Surgery and Dermatology
    Department of Surgery - Northwestern Memorial Hospital
    Wilmette, Illinois, United States

Please join us for a presentation on OGSIVEO™ (nirogacestat) the first and only FDA-approved therapy for adult patients with progressing desmoid tumors who require systemic treatment.